Sanofi To Get $60M In Allegra Deal With Barr, Teva
Generic-drug makers Barr Pharmaceuticals Inc. and Teva Pharmaceuticals Industries Ltd. will pay Sanofi-Aventis $30 million each plus royalties to settle U.S. patent infringement litigation over generic versions of the allergy drug...To view the full article, register now.
Already a subscriber? Click here to view full article